DecisionDatabases.com, recently added a new report to its database. Europe Diabetes POC analyzer Industry 2016 Market Research Report gives a 360 degree view of theDiabetes POC analyzer industry.
The global market size of Point of Care (PoC) Molecular Diagnostics is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024.
Blood Gas and Electrolyte Analyzers Market Size By Modality (Bench Top, Portable), By Product (Blood Gas Analyzers, Electrolyte Analyzers, Combined Analyzers, Consumables)
Avail more information from Sample Brochure of report @ http://bit.ly/2AaydY3 A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Global POC Lipid Testing Market and future opportunities are provided in the report.
Visit at: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-us-point-of-care-poc-infectious-disease-testing-supplier-shares-and-country-forecasts-market Research Beam’s report on 2015-2019 Future Horizons and Growth Strategies in the US Point-of-Care/POC Infectious Disease Testing Market: Supplier Shares and Country Forecasts” contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
The report “Coagulation/Hemostasis Analyzers Market by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals) - Forecast to 2019”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Get more details @ http://bit.ly/2h9pbzB Major companies operating in the blood gas and electrolyte analyzers market include Instrumentation Laboratories, Roche Diagnostics, Siemens Healthcare, Alera Medical, Radiometer, and among others.
The Report on “Point of Care POC Testing Market Size, Share, Growth, Profit, Analysis, Trends and Strategy 2015" added by Research Beam Enquiry about report: http://www.researchbeam.com/2015-emerging-point-of-care-poc-testing-cancer-clinics-ambulatory-centers-surgery-centers-nursing-homes-birth-centers-supplier-shares-volume-and-sales-forecasts-for-300-tests-market/enquire-about-report
Avail more information from Sample Brochure of report @ http://tinyurl.com/gre5az9 This new 1,230-page report contains 343 tables, and provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies. Read analysis @ http://tinyurl.com/jklw5v3
For more information kindly visit : https://www.bharatbook.com/diagnostics-market-research-reports-193573/in-vitro-diagnostics-technologies-global.html Bharat Book Bureau provides the report, on “ In Vitro Diagnostics: Technologies and Global Market report ”.The scope of this study is global. The report analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares.
Bharat Book Bureau provides the report, on “Research Report on In Vitro Diagnostics Technologies and Global Markets” This report In Vitro Diagnostics Technologies and Global Markets, will thereby provide a detailed analysis https://www.bharatbook.com/diagnostics-market-research-reports-193573/in-vitro-diagnostics-technologies-global.html
Get more details @ http://bit.ly/2l1txJB Major companies operating in the blood gas and electrolyte analyzers market include Instrumentation Laboratories, Roche Diagnostics, Siemens Healthcare, Alera Medical, Radiometer, and among others.
The global blood gas and electrolyte analyzers market is expected to grow at a CAGR of 4.7% during the forecast period (2016-2024). It is estimated to reach around USD 715 million by 2024. These analyzers are used to measure the acidity level in blood.
The report “Urinalysis Market by Product (Dipstick, Reagent, Urine Analyzer, POC), Test Type (Biochemical, Sediment, Microscopic), Application (Diagnosis, Diabetes, UTI, Kidney Disease, Pregnancy), End User (Hospital, Research Institute, Home) - Forecast to 2019”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the urinalysis market along with the estimates and forecasts of the revenue and share analysis.
According to a new market research report " Urinalysis Market By Product (Dipstick, Reagent, Urine Analyzer, PoC), Test Type (Biochemical, Sediment, Microscopic), Application (Diagnosis, Diabetes, UTI, Kidney Disease, Pregnancy), End User (Hospital, Research Institute, Home) - Forecast to 2019", published by MarketsandMarkets, the Urinalysis Market is expected to reach around $1.28 Billion by 2019 with a CAGR of around 7-6 % during the forecast period 2014 to 2019.
Japan Clinical Chemistry Market Outlook to 2021, provides key market data on the Japan Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.
Market Size – USD 3.46 Billion in 2021, Market Growth – at a CAGR of 7.2%, Market Trends – Rising prevalence of chronic renal disease, hypertension, and diabetes and well-established sophisticated healthcare in the North American region
Global Point of Care Diagnostics (POC) Market Analysis By Product, By Application, And Segment Forecasts To 2020 is a latest Medical Devices Industry report.
The global urinalysis market size is expected to reach USD 6.49 Billion at a steady revenue CAGR of 7.2% in 2030, according to latest analysis by Emergen Research. Rising prevalence of UTI, diabetes, and kidney diseases such as Chronic Kidney Disease (CKD), polycystic kidney disease , and acute kidney failure, rapid advancements in technology in urinalysis methods for early diagnosis, and growing adoption of automated urinalysis in various hospitals, clinics, and other healthcare centers are major factors driving market revenue growth.
U.S. glucose testing is undergoing a significant transition, driven by new analytical technologies and developments in diabetes treatment. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, several segments of the market, such as home testing devices for diabetes management and point of care (POC) instruments for use in professional settings, will exhibit strong growth. For More Details: http://goo.gl/x4eoeZ
iGATE Research has released a research report on “Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025” Click here to view the complete report: www.igateresearch.com Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
Hemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. Its clinical utility and improvements in its accuracy and implementation of standardized protocols have translated into continued market growth. For More Details: http://goo.gl/VSnyhk
Increasing government initiatives to promote the use of Point of Care Testing products and the rise in the geriatric population are driving the demand of the market.
iGATE Research has released a research report on “United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=166 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
Diabetic foot ulcers (DFUs) are a common complication of diabetes. With the increasing prevalence of diabetes across all markets the number of patients suffering from DFUs is also expected to rise. The global DFU therapeutics market is set to enter an exciting phase with the potential launch of three wound-healing agents in the next five years. The first two topical antibacterial are also expected to be launched in the US and the five major EU markets. With the advent of these new product launches, the size of the DFU market is expected to grow substantially by 2017. For more details: http://www.researchonglobalmarkets.com/opportunityanalyzer-diabetic-foot-ulcers-opportunity-analysis-and-forecast-to-2017.html
For more information kindly visit : https://www.bharatbook.com/healthcare-market-research-reports-681212/infectious-disease-point-of-care-diagnostic-testing.html Bharat Book Bureau provides the report, on “ Report on Infectious Disease : Physician Offices, Emergency Rooms, Surgery Centers, Birth Centers [2016] ”.Bharat Book Bureau provides the report, on “ Report on Infectious Disease : Physician Offices, Emergency Rooms, Surgery Centers, Birth Centers [2016] ”.
Complete report on In-Vitro Diagnostics (IVD) market spread across 81 pages providing 4 company profiles and 3 tables and 48 charts is now available at http://www.marketreportsonline.com/547317.html.
iGATE Research has released a research report on "Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profiles – Global Forecast to 2025” Click here to view the complete report: www.igateresearch.com Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
According to Renub Research Global Drug Abuse Testing Market will surpass US$ 5 Billion US$ by the year-end of 2025. Forecast by Products & Region (2019 -2025)
As per FMI’s analysis, the following players operate within the global zika virus testing market: EUROIMMUN US Inc. Creative Diagnostics Quest Diagnostics Artron Laboratories Inc. RapiGEN Inc.
In-vitro diagnostics are medical examinations that assist doctors to diagnose a patient’s condition and provide appropriate treatments. Blood, tissue, saliva, or other samples from a human’s body are collected which on analyzing can help detect infections, diseases and other conditions
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
The global patient registry software market is expected to reach USD 1,314.3 Million by 2021 from USD 734.7 Million in 2016, at a CAGR of 12.3% during the forecast period.
The OncoHealth Corporation offers protein biomarker diagnostics and screening products for detection of oncoproteins. Browse full report @ http://bit.ly/1NcEjHW
Point-of-care (POC) diagnostics or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours.
“2014 Strategies for the Spanish Clinical Chemistry and Immunodiagnostic Market” is a new strategic analysis of major business opportunities emerging in the Spanish clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the Spanish market; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years. The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.
Global Biochips market Click to Get Sample @ http://goo.gl/NWSjx4 . It is categorized into four major segments, namely, hospitals & diagnostic centers, biotechnology & pharmaceutical companies, academic & research institutes, and other end users (blood banks, CROs, forensic labs, point-of-care settings, home health agencies, nursing homes, and local public health laboratories). Abbott Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), Illumina, Inc. (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and F. Hoffmann-La Roche AG (Switzerland) are the major players in the biochips market.
The first step to treating any health condition is diagnosis.In our special issue of “10 Leading Diagnostic Solution Providers 2019”, we have featured top diagnostic companies that have not only enabled correct detection of diseases but have aided in early diagnosis and are contributing largely to the better tomorrow of healthcare.
Real Time PCR Technology & Reagents Dr. Tehseen Qayum General Manager Details Available on Request Avian A Screening & H5N1 Chlamydia Trachomatis Ureaplasma parvum ...
The global in vitro diagnostics (IVD) market should reach $102.4 billion by 2022 from $74.1 billion in 2017 at a compound annual growth rate (CAGR) of 6.7%, from 2017 to 2022.
Aarti Pharmalabs Ltd specializes in the clinical phase and commercial production of APIs and NCEs, intermediates, regulatory starting materials, key building blocks and xanthine derivatives. Our offerings include process R&D, analytical method development and validations, stability studies, scale-up and process optimization, process validations and commercial production. The quality and purity of our products have enabled us to be the leading Active Pharmaceutical ingredients manufacturers in India.
The global In-vitro diagnostics (IVD) market is estimated to reach USD 80 Billion, in 2024. In 2014, India holds total 1% market share of global IVD market. To get more details read our report: https://bit.ly/2fD38Do